R
Rafael Pulido
Researcher at Ikerbasque
Publications - 10
Citations - 23
Rafael Pulido is an academic researcher from Ikerbasque. The author has contributed to research in topics: Medicine & Cancer research. The author has an hindex of 1, co-authored 2 publications receiving 7 citations. Previous affiliations of Rafael Pulido include University of the Basque Country.
Papers
More filters
Journal ArticleDOI
High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma.
Rosa Guarch,Charles H. Lawrie,Gorka Larrinaga,Javier C. Angulo,Rafael Pulido,Rafael Pulido,José I. López +6 more
TL;DR: It is concluded that high levels of intratumor heterogeneity characterize the immunohistochemical expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinomas.
Journal ArticleDOI
Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer
Caroline E. Nunes-Xavier,Janire Mingo,Maite Emaldi,Karine Flem-Karlsen,Gunhild Mari Mælandsmo,Øystein Fodstad,Roberto Llarena,José I. López,Rafael Pulido +8 more
TL;DR: The notion that expression of specific PDH complex components is related with AR signaling in PCa tumors is supported, with PDK2 expression associated with poor PCa prognosis highlighted.
Journal ArticleDOI
Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate Cancer
Claudia Manini,Alba González,D. Büchser,Jorge García-Olaverri,A. Urresola,A. Ezquerro,Iratxe Fernández,Roberto Llarena,Iñaki Zabalza,Rafael Pulido,Rafael Pulido,Arkaitz Carracedo,Alfonso Gomez-Iturriaga,José I. López +13 more
TL;DR: Oligometastatic prostate adenocarcinoma does not have a specific clinical-pathologic profile, however, some histologic and immunohistochemical parameters of routine use may help with making therapeutic decisions.
Journal ArticleDOI
Hopes on immunotherapy targeting B7-H3 in neuroblastoma
TL;DR: In this paper , the authors summarize the current status of neuroblastoma targeted therapies, with a focus on B7-H3 as a promising novel immunoregulatory therapeutic target for high-risk NCB.
Journal ArticleDOI
Functional analysis of PTEN variants of unknown significance from PHTS patients unveils complex patterns of PTEN biological activity in disease
Leire Torices,Janire Mingo,Isabel Rodríguez-Escudero,Teresa Fernández-Acero,Sandra Luna,Caroline E. Nunes-Xavier,José I. López,Fátima Mercadillo,M. T. Curras,Miguel Urioste,María Molina,Víctor J. Cid,Rafael Pulido +12 more